Reinfection with SARS-CoV-2 Omicron BA.4 and BA.5 variants

被引:1
|
作者
Nguyen, Nhu Ngoc [1 ,2 ]
Houhamdi, Linda [1 ,2 ]
Meddeb, Line [2 ]
Colson, Philippe [2 ,3 ]
Gautret, Philippe [1 ,2 ,4 ]
机构
[1] Aix Marseille Univ, AP HM, IRD, SSA,VITROME, Marseille, France
[2] IHU Mediterranee Infect, Marseille, France
[3] Aix Marseille Univ, AP HM, IRD, MEPHI, Marseille, France
[4] Inst Hosp Univ Mediterranee Infect, VITROME, 19-21 Blvd Jean Moulin, F-13385 Marseille 05, France
关键词
D O I
10.1002/jmv.29033
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England
    Aziz, Nurin Abdul
    Nash, Sophie Grace
    Zaidi, Asad
    Nyberg, Tommy
    Groves, Natalie
    Hope, Russell
    Bernal, Jamie Lopez
    Dabrera, Gavin
    Thelwall, Simon
    JOURNAL OF INFECTION, 2023, 87 (01) : E8 - E11
  • [32] What Omicron’s BA.4 and BA.5 variants mean for the pandemic
    Ewen Callaway
    Nature, 2022, 606 : 848 - 849
  • [33] Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
    Bruel, Timothee
    Stefic, Karl
    Nguyen, Yann
    Toniutti, Donatella
    Staropoli, Isabelle
    Porrot, Francoise
    Guivel-Benhassine, Florence
    Bolland, William-Henry
    Planas, Delphine
    Hadjadj, Jerome
    Handala, Lynda
    Planchais, Cyril
    Prot, Matthieu
    Simon-Loriere, Etienne
    Andre, Emmanuel
    Baele, Guy
    Cuypers, Lize
    Mouthon, Luc
    Mouquet, Hugo
    Buchrieser, Julian
    Seve, Aymeric
    Prazuck, Thierry
    Maes, Piet
    Terrier, Benjamin
    Hocqueloux, Laurent
    Schwartz, Olivier
    CELL REPORTS MEDICINE, 2022, 3 (12)
  • [34] Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5
    Tuyji-Tok, Yesim
    Yucebag, Ebru
    Keles, Ayse Betul
    Kilincarslan, Ayse Ceylan
    Nohut, Okan Kadir
    Salman-Yilmaz, Seda
    Kuskucu, Mert Ahmet
    Midilli, Kenan
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (03): : 192 - 198
  • [35] Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
    Torres, Carolina
    Nabaes Jodar, Mercedes
    Acuna, Dolores
    Zambrana Montano, Romina Micaela
    Alberto Culasso, Andres Carlos
    Fernando Amadio, Ariel
    Aulicino, Paula
    Ceballos, Santiago
    Cacciabue, Marco
    Debat, Humberto
    Dus Santos, Maria Jose
    Florencia Eberhardt, Maria
    Espul, Carlos
    Fay, Fabian
    Ailen Fernandez, Maria
    Fernandez, Franco
    Fernandez Munoz, Juan Manuel
    Ferrini, Florencia
    Gallego, Fernando
    Angelica Giri, Adriana
    Cerri, Agustina
    Bolatti, Elisa
    Ines Gismondi, Maria
    Goya, Stephanie
    Gramundi, Ivan
    Matias Irazoqui, Jose
    Alberto Konig, Guido
    Leiva, Viviana
    Lucero, Horacio
    Marquez, Nathalie
    Nardi, Cristina
    Ortiz, Belen
    Pianciola, Luis
    Beatriz Pintos, Carolina
    Fabiana Puebla, Andrea
    Victoria Rastellini, Carolina
    Ezequiel Rojas, Alejandro
    Sfalcin, Javier
    Suarez, Ariel
    Tittarelli, Estefania
    Toro, Rosana
    Vanina Villanova, Gabriela
    Cecilia Ziehm, Maria
    Carla Zimmermann, Maria
    Zunino, Sebastian
    Valinotto, Laura
    Viegas, Mariana
    VIRUSES-BASEL, 2023, 15 (02):
  • [36] Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
    Jian, Fanchong
    Yu, Yuanling
    Song, Weiliang
    Yisimayi, Ayijiang
    Yu, Lingling
    Gao, Yuxue
    Zhang, Na
    Wang, Yao
    Shao, Fei
    Hao, Xiaohua
    Xu, Yanli
    Jin, Ronghua
    Wang, Youchun
    Xie, Xiaoliang Sunney
    Cao, Yunlong
    LANCET INFECTIOUS DISEASES, 2022, 22 (11): : 1535 - 1537
  • [37] Seroepidemiology of SARS-CoV-2 Virus in Healthcare Workers before Circulation of the Omicron Sublineages BA.4/BA.5 in Vojvodina, Serbia
    Ristic, Mioljub
    Vukovic, Vladimir
    Patic, Aleksandra
    Markovic, Milos
    Petrovic, Vladimir
    VACCINES, 2022, 10 (12)
  • [38] SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
    Emmelot, Maarten E. E.
    Vos, Martijn
    Boer, Mardi C. C.
    Rots, Nynke Y. Y.
    van Els, Cecile A. C. M.
    Kaaijk, Patricia
    VIRUSES-BASEL, 2023, 15 (01):
  • [39] Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
    Ackerson, Bradley K.
    Bruxvoort, Katia J.
    Qian, Lei
    Sy, Lina S.
    Qiu, Sijia
    Tubert, Julia E.
    Lee, Gina S.
    Ku, Jennifer H.
    Florea, Ana
    Luo, Yi
    Bathala, Radha
    Stern, Julie
    Choi, Soon K.
    Takhar, Harpreet S.
    Aragones, Michael
    Marks, Morgan A.
    Anderson, Evan J.
    Zhou, Cindy Ke
    Sun, Tianyu
    Talarico, Carla A.
    Tseng, Hung Fu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [40] Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD
    An, Zizhe
    Bu, Changkai
    Shi, Deling
    Chen, Qingqing
    Zhang, Bin
    Wang, Qingchi
    Jin, Lan
    Chi, Lianli
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 259